Assets, Current in USD of NovaBridge Biosciences from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
NovaBridge Biosciences quarterly Assets, Current history and change rate from Q4 2019 to Q2 2025.
  • NovaBridge Biosciences Assets, Current for the quarter ending 30 Jun 2025 was $167,640,000.
Source SEC data
View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $167,640,000 30 Jun 2025 6-K 06 Oct 2025 2025 Q2
Q4 2024 $176,693,000 -$153,219,000 -46% 31 Dec 2024 6-K 06 Oct 2025 2025 Q2
Q4 2023 $329,912,000 -$195,877,000 -37% 31 Dec 2023 20-F 03 Apr 2025 2024 FY
Q4 2022 $525,789,000 -$224,567,000 -30% 31 Dec 2022 20-F 01 May 2023 2022 FY
Q2 2022 $644,165,000 30 Jun 2022 6-K 10 Nov 2022 2022 Q2
Q4 2021 $750,356,000 -$68,597,000 -8.4% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $818,953,000 +$623,411,000 +319% 31 Dec 2020 20-F 28 Apr 2021 2020 FY
Q3 2020 $472,543,000 30 Sep 2020 6-K 05 Feb 2021 2020 Q3
Q4 2019 $195,542,000 31 Dec 2019 20-F 29 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.